EUVIMEDOpdag EUVIMED
Multizentrische StudieOpen access · CC BY 4.0

Multicentric Longitudinal Prospective Study in a European Cohort of MYO7A Patients: Disease Course and Implications for Gene Therapy

Francesco Testa, Ester Carreño, L Ingeborgh van den Born, Paolo Melillo, Irene Perea-Romero, Valentina Di Iorio, Giulia Risca, Clemente Maria Iodice, Ronald J E Pennings, Marianthi Karali, Sandro Banfi, Alberto Auricchio and 3 more

Investigative Ophthalmology & Visual Science · 2024

DOI: 10.1167/iovs.65.6.25 ↗

At a glance

Multizentrische Studie in Investigative Ophthalmology & Visual Science, 2024. Written by Francesco Testa and 14 co-authors. Institution: Eye Clinic, Multidisciplinary Department of Medical, Surgical and Dental Sciences, University of Campania "Luigi Vanvitelli," Naples, Italy. Major MEDLINE topics: Tomography, Optical Coherence, Visual Acuity, Electroretinography, Myosin VIIa. Cited 7 times so far (Crossref); 33 references. The full text is freely available (open access, CC BY 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Purpose

We investigated the natural history of retinal dystrophy owing to variants in the MYO7A gene.

Methods

Fifty-three patients (mean age, 33.6 ± 16.7 years) with Usher syndrome owing to biallelic, mostly pathogenic, variants in MYO7A underwent baseline and two annual follow-up visits. Best-corrected visual acuity (BCVA), semiautomatic kinetic visual field, full-field electroretinogram, color fundus imaging, microperimetry, spectral-domain optical coherence tomography, and fundus autofluorescence were assessed.

Results

At baseline, all patients presented with decreased BCVA (66.4 ± 17.9 Early Treatment Diabetic Retinopathy score and 59.5 ± 21.7 Early Treatment Diabetic Retinopathy score, in the better- and worse-seeing eyes, respectively), restricted semiautomatic kinetic visual field (III4e area, 3365.8 ± 4142.1°2; 4176.4 ± 4400.3°2) and decreased macular sensitivity (9.7 ± 9.9 dB; 9.0 ± 10.2 dB). Spectral-domain optical coherence tomography revealed reduced central macular thickness (259.6 ± 63.0 µm; 250.7 ± 63.3 µm) and narrowed ellipsoid zone band width (2807.5 ± 2374.6 µm; 2615.5 ± 2370.4 µm). Longitudinal analyses (50 patients) showed a significant decrease of BCVA in better-seeing eyes, whereas no changes were observed in worse-seeing eyes for any parameter. BCVA, semiautomatic kinetic visual field (III4e and V4e) and macular sensitivity were related significantly to age at baseline. Hyperautofluorescent foveal patch (16 eyes [31.4%]) and abnormal central hypoautofluorescence (9 eyes [17.6%]) were significantly associated with worse morphological and functional read-outs compared with the hyperautofluorescent ring pattern (22 eyes [43.1%]).

Conclusions

Our European multicentric study offers the first prospective longitudinal analysis in one of the largest cohorts of MYO7A patients described to date, confirming the slow disease progression. More important, this study emphasizes the key role of fundus autofluorescence patterns in retinal impairment staging and advocates its adoption as an objective biomarker in patient selection for future gene therapy clinical trials.

Subjects

MeSH terms (MEDLINE)

Tomography, Optical CoherenceVisual AcuityElectroretinographyMyosin VIIaVisual FieldsUsher SyndromesGenetic TherapyHumansMaleFemaleAdultProspective StudiesMiddle AgedYoung AdultAdolescentChildVisual Field TestsEuropeFluorescein AngiographyFollow-Up StudiesAgedLongitudinal StudiesDisease ProgressionMyosinsRetina

Substances

Myosin VIIaMYO7A protein, humanMyosins

Authors and institutions

  • Eye Clinic, Multidisciplinary Department of Medical, Surgical and Dental Sciences, University of Campania "Luigi Vanvitelli," Naples, Italy.
  • Department of Ophthalmology, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.
  • The Rotterdam Eye Hospital, Rotterdam, the Netherlands.
  • Department of Genetics, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.
  • Center for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.
  • Bicocca Bioinformatics, Biostatistics and Bioimaging Centre, Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.

Cite

APA

Testa, F., Carreño, E., van den Born, L. I., Melillo, P., Perea-Romero, I., Di Iorio, V., Risca, G., Iodice, C. M., Pennings, R. J. E., Karali, M., Banfi, S., Auricchio, A., Galimberti, S., Ayuso, C., & Simonelli, F. (2024). Multicentric Longitudinal Prospective Study in a European Cohort of MYO7A Patients: Disease Course and Implications for Gene Therapy. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.65.6.25

Vancouver

Testa F, Carreño E, van den Born LI, Melillo P, Perea-Romero I, Di Iorio V, et al. Multicentric Longitudinal Prospective Study in a European Cohort of MYO7A Patients: Disease Course and Implications for Gene Therapy. Investigative Ophthalmology & Visual Science. 2024. doi:10.1167/iovs.65.6.25

BibTeX
@article{Testa2024,
  author = {Testa, Francesco and Carreño, Ester and van den Born, L Ingeborgh and Melillo, Paolo and Perea-Romero, Irene and Di Iorio, Valentina and Risca, Giulia and Iodice, Clemente Maria and Pennings, Ronald J E and Karali, Marianthi and Banfi, Sandro and Auricchio, Alberto and Galimberti, Stefania and Ayuso, Carmen and Simonelli, Francesca},
  title = {Multicentric Longitudinal Prospective Study in a European Cohort of MYO7A Patients: Disease Course and Implications for Gene Therapy},
  journal = {Investigative Ophthalmology & Visual Science},
  year = {2024},
  doi = {10.1167/iovs.65.6.25}
}
Start for free →